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FIG 1. Comparison of allergen-specific IgG levels (ISAC standardized unit
[ISU]) measured in different plasma dilutions of 4 mothers with allergen-
specific IgG levels in their breast milk samples.
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Transmission of allergen-specific IgG and IgE
from maternal blood into breast milk visual-
ized with microarray technology
To the Editor:
Data from experimental animal models have previously shown
that allergen-specific IgG antibodies are transmitted from the
mother to the offspring via breast milk1,2 and have provided evi-
dence that the transmitted allergen-specific IgG antibodies protect
specifically against allergic sensitization.2 In some studies, it has
been demonstrated for humans that breast-feeding has a prophy-
lactic effect against atopic disease but there are also reports
arguing against this and the underlying mechanisms are not
known.3 There is evidence that IgG antibodies against bacterial
antigens (ie, pneumococcal antigens) are transferred from the
blood of mothers into their breast milk.4 Furthermore, it was
possible to detect IgA and IgG against different food antigens
in human serum, saliva, colostrums, and milk samples.5 Another
study found that total IgE levels in breast milk and blood were
associated but allergen-specific IgE was not analyzed.6
With the FP7-funded European Union research program
Mechanisms of the Development of ALLergy (MeDALL;
http://medall-fp7.eu/), we have recently developed a microarray
containing a large number of purified natural and recombinant
respiratory, food, and insect allergens that allows highly sensi-
tive measurement of allergen-specific IgE and IgG levels with
minute amounts of blood.7 A major advantage of the microarray
technology is that it allows one to measure antibody reactivities 2014 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/3.0/).toward a large panel of different allergens. Here, we investi-
gated whether the MeDALL chip is suitable for (1) the measure-
ment of allergen-specific IgG and IgE levels in human breast
milk samples, (2) whether there is a transmission of allergen-
specific antibodies from blood into breast milk, and (3) whether
the reactivity profile of allergens recognized by antibodies in
blood and milk is similar. For this purpose, we analyzed plasma
and breast milk samples from sensitized (n 5 23) and nonal-
lergic mothers (n 5 6) from the ALADDIN birth cohort.8
None of the mothers was on allergen-specific immunotherapy.
Maternal blood samples were collected in the period around
delivery (21 to 12 months), and the breast milk samples
were obtained 2 months after delivery. The study was approved
by the local Research Ethical Committee, and written informed
consent was obtained from all families.
The breast milk samples were centrifuged for 10 minutes at
2500g before use to remove the lipids. For comparison of IgG
titers in plasma and breast milk, the plasma samples were diluted
1:50, 1:100, 1:200, and 1:400 before analysis. Microarrays were
incubated with 30 mL of the plasma dilutions or undiluted breast
milk samples and allergen-specific IgG and IgE antibodies were
detected with fluorophore-conjugated anti-IgG and anti-IgE
antibodies, respectively.7 The fluorescence intensities were
measured with a biochip scanner. Results were expressed in
ISAC standardized units (Thermofisher, Uppsala, Sweden).
Correlation coefficients were calculated with SPSS.
Detailed analysis of allergen-specific IgG and IgE levels in
plasma and breast milk samples indicated that allergen-specific
IgG antibodies are transmitted from the blood into breast milk in a
highly specific manner and that breast milk IgG mirrored the
profile of IgG reactivity in the blood (see Fig E1 in this article’s
Online Repository at www.jacionline.org). A comparison of
allergen-specific IgG levels measured in 4 plasma dilutions with
that of undiluted breast milk samples (Fig 1) indicated that
allergen-specific IgG levels in breast milk were approximately
200- to 400-fold lower than in plasma. Allergen-specific IgG re-
activities in plasma and breast milk were significantly correlated;
for the 1:200 dilution, Spearman correlation coefficient was 0.608
(P < .001) and for the 1:400 dilution, Spearman correlation coef-
ficient was 0.604 (P < .001) (Fig 2). Detailed results are displayed
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FIG 2. Correlation of allergen-specific IgG levels (ISAC standardized unit [ISU]) in plasma samples (left:
dilution 1:200; right: dilution 1:400) from 4 mothers (the donors are labeled in different colors) with
allergen-specific IgG levels in their corresponding undiluted breast milk samples.
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allergens, plasma- and milk-derived IgG antibody reactivities
were correlated. However, in certain instances (eg, milk allergens
recognized by donor 3), specific IgGs were high in plasma but did
not appear in milk; in some other cases, allergen-specific IgG was
detected only in milk but not in plasma (Fig E1). Possible expla-
nations for lack of allergen-specific IgG binding in milk are that
certain antigens are present in milk and inhibit IgG
binding and/or low affinity/avidity of IgG may prevent binding
despite high titers in blood. In fact, the presence of certain respi-
ratory and food allergens in breast milk has been recently demon-
strated.9,10 However, milk-specific IgG may appear because of
local IgG production without corresponding IgG in blood.
The presence of allergen-specific IgG in breast milk may be
due to specific transmission of allergen-specific IgG from the
blood of mothers into their breast milk or eventually because of
local production. For transmission, active transport by the IgG
receptor FcRn, which in fact is expressed in the human mammary
gland,11 and/or transudation from blood into the mammary
glands, as was found for allergen-specific IgG in mucosal fluids,
may be considered.12 Interestingly, for mothers with high levels
of allergen-specific IgE in their plasma (donors 1, 9, 13, 15, 16,
and 19), we also found that specific IgE antibodies were present
in breast milk. In all but 1 case (donor 3, Phl p 5–specific IgE),
the presence of allergen-specific IgE was associated with levels
of IgE in the blood. The allergen-specific IgE reactivity profiles
in blood and breast milk are summarized in detail in Figs E1
and E2 in this article’s Online Repository at www.jacionline.org.
In none of the 6 nonallergic mothers (donors 24-29), who
served as negative controls, allergen-specific IgE was detected in
plasma or in breast milk, demonstrating the specificity of IgE test
results (Fig E2).
Our results thus demonstrate that allergen-specific IgG and IgE
antibodies with similar specificity are present in blood and in
breast milk. Furthermore, our study shows that the MeDALL
allergen chip is suitable for the measurement of allergen-specific
IgG and IgE antibodies not only in blood but also in breast milk,
which opens the possibility to study the transmission of allergen-
specific IgG antibodies from mothers to offsprings on the
development of allergic sensitization in birth cohorts.Heidrun Hochwallner, PhDa
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